Novo Holdings A/S Q3 2017 Filing
Filed November 14, 2017
Portfolio Value
$768.3B
Holdings
17
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INGNINOGEN INC | 3,549,320 | $337.5B | 43.93% | |
| 2 | XLRNACCELERON PHARMA INC | 1,553,937 | $58.0B | 7.55% | |
| 3 | —DERMIRA INC | 1,921,580 | $51.9B | 6.75% | |
| 4 | CRVSCORVUS PHARMACEUTICALS INC | 3,244,046 | $51.7B | 6.73% | |
| 5 | ANABANAPTYSBIO INC | 1,190,604 | $41.6B | 5.42% | |
| 6 | AKBAAKEBIA THERAPEUTICS INC | 1,887,535 | $37.1B | 4.83% | |
| 7 | —FLEXION THERAPEUTICS INC | 1,500,000 | $36.3B | 4.72% | |
| 8 | —RA PHARMACEUTICALS INC | 2,031,562 | $29.7B | 3.86% | |
| 9 | MRUSMERUS N V | 1,410,417 | $28.0B | 3.65% | |
| 10 | —NABRIVA THERAPEUTICS PLC | 2,903,800 | $23.8B | 3.10% | |
| 11 | RETAEURREATA PHARMACEUTICALS INC | 592,794 | $18.4B | 2.40% | |
| 12 | KALVKALVISTA PHARMACEUTICALS INC | 2,725,283 | $18.3B | 2.39% | |
| 13 | —INVUITY INC | 1,363,848 | $12.1B | 1.58% | |
| 14 | VRNAVERONA PHARMA PLC | 740,740 | $11.4B | 1.48% | |
| 15 | —WRIGHT MED GROUP N V | 4,622,032 | $7.2B | 0.93% | |
| 16 | CRSPCRISPR THERAPEUTICS AG | 223,317 | $4.0B | 0.52% | |
| 17 | —APOLLO ENDOSURGERY INC | 274,472 | $1.3B | 0.17% |